Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice
Year: 2015
Type: article
Abstract: Telomere shortening is common in bone marrow failure syndromes such as dyskeratosis congenita (DC), aplastic anemia (AA) and myelodysplastic syndromes (MDS). However, improved knowledge of the lineage-specific consequences of telomere erosion and restoration of telomere length in hematopoietic progenitors is required to advance therapeutic approaches. We have employed a reversible murine model of telomerase deficiency to compare the dependence of erythroid and myeloid lineage differentiation on telomerase activity. Fifth generation Tert-/- (G5 Tert-/-) mice with shortened telomeres have significant anemia, decreased erythroblasts and reduced hematopoietic stem cell (HSC) populations associated with neutrophilia and increased myelopoiesis. Intracellular multiparameter analysis by mass cytometry showed significantly reduced cell proliferation and increased sensitivity to activation of DNA damage checkpoints in erythroid progenitors and in erythroid-biased CD150hi HSC, but not in myeloid progenitors. Strikingly, Cre-inducible reactivation of telomerase activity restored hematopoietic stem and progenitor cell (HSPC) proliferation, normalized the DNA damage response, and improved red cell production and hemoglobin levels. These data establish a direct link between the loss of TERT activity, telomere shortening and defective erythropoiesis and suggest that novel strategies to restore telomerase function may have an important role in the treatment of the resulting anemia.
Source: PLoS ONE
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,382
Funders: Burroughs Wellcome Fund, California Institute for Regenerative Medicine, Leukemia and Lymphoma Society, National Institutes of Health, Medical Research Council, National Health and Medical Research Council, National Institute on Aging, National Heart, Lung, and Blood Institute, National Eye Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Stanford Cancer Institute
Awards: Telomere extension using nucleoside-modified mRNA and exosomes as a novel therape, G2950387133, Basic and Translational Research iPSC-based hematologic and vascular therapies, Progenitor Cell Biology Consortium Administrative Coordinating Center, The Center for Systemic Control of Cyto-Networks, Safe, Rapid Telomere Extension to Prevent and Treat Hypertension, Software & Hardware Inference Engines for Automated Determination of Primary Cell, Clinical and Laboratory Studies of Malignant Lymphomas, G7063900871, G7398253753, G8343853698, Reversing Cellular immortality in cancer, Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro
OpenAlex ID: W2243713984
